Protocol summary

Study aim
Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity
Design
A clinical trial with a control group with parallel groups, single-blind, randomized and sampling groups was 40 patients. In this study, there was no factor in the classification of patients in the two groups.
Settings and conduct
A randomized, single-blind clinical trial will be carried out at the Shiraz University of Medical Sciences , Namazi Hospital. BUN and Scr values will be determined for each patient every other day during the study period (days 1, 3, 5 and 7). GFR will be also calculated every other day by MDRD formula. Serum potassium and magnesium levels will be determined at days 1 & 7 of the intervention.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Age over 15 years, Receive amphotericin for at least 7 days, No history of kidney disease (including chronic kidney disease) and hemodialysis, Signing up the informed consent form Exclusion criteria: Cardiac failure class 3 and 4, Known liver failure, Known kidney failure, Alkalosis (pH greater than 7.5 or sodium bicarbonate plasma greater than 30 meq / lit), symptomatic Hypocalcemia, hypokalemia or hypomagnesemia, Sensitivity and any adverse effect that occurred after the injection of bicarbonate in the patient.
Intervention groups
group 1:Includes 20 patients with 1000 ml normal saline 0.9% equivalent to 159 mEq in two divided doses (500 ml) before and after infusion of amphotericin that is given to patients. group2:Includes 20 patients who received 500 ml of normal saline before injection of amphotericin and 1.5 vial sodium bicarbonate vial in 500 cc dextrose water, equivalent to the normal saline mEq 159, sodium bicarbonate that is given to patients.
Main outcome variables
Nephrotoxicity of amphotericin B

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20161010030246N4
Registration date: 2019-09-08, 1398/06/17
Registration timing: registered_while_recruiting

Last update: 2019-09-08, 1398/06/17
Update count: 0
Registration date
2019-09-08, 1398/06/17
Registrant information
Name
Iman Karimzadeh
Name of organization / entity
Shiraz University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 71 3242 4128
Email address
karimzadee@sums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-10-23, 1397/08/01
Expected recruitment end date
2020-03-20, 1399/01/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity
Public title
Comparison effect of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration in reducing of amphotericin B-induced nephrotoxicity
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Age over 15 years Receive amphotericin for at least 7 days No history of kidney disease (including chronic kidney disease) and hemodialysis Signing up the informed consent form
Exclusion criteria:
Heart failure class 3 and 4 Known liver failure Known acute or chronic kidney disease Alkalosis (pH greater than 7.5 or sodium bicarbonate plasma greater than 30 meq / lit) Symptomatic hypocalcemia, hypokalemia or hypomagnesemia Sensitivity and any adverse effect that occurred after the injection of bicarbonate in the patient.
Age
From 15 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
Sample size
Target sample size: 40
Randomization (investigator's opinion)
Randomized
Randomization description
Clinical trials are simple randomized, one-blind, and placebo-free that the patient did not know. The possibility of double-blind due to the lack of a clean room and the required facilities as well as the different appearance of sodium bicarbonate and sodium chloride Did not have. unit of randomization is individual a randomization method using a random number table.
Blinding (investigator's opinion)
Single blinded
Blinding description
This study was conducted in a single blind setting that That the participants are blind in this study. It is impossible to conduct this clinical trial as double-blinded due to the lack of a clean room and the required facilities as well as the appearance of the sodium bicarbonate and sodium chloride looks different.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Shiraz University of Medical Sciences
Street address
Street Karim Khan Zand
City
shiraz
Province
Fars
Postal code
71348-14336
Approval date
2019-05-19, 1398/02/29
Ethics committee reference number
IR.SUMS.REC.1398.460

Health conditions studied

1

Description of health condition studied
Nephrotoxicity
ICD-10 code
N10
ICD-10 code description
Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

Primary outcomes

1

Description
Amphotericin b nephrotoxicity defined by either doubling of Scr from the baseline value or ≥50 % decrease in GFR
Timepoint
SCr and GFR are measured every other day during the intervention (Days 1, 3, 5 & 7).
Method of measurement
Measurement of serum creatinine using an autoanalyzer device

2

Description
Electrolyte disorders including hypokalemia (serum level potassium below 3 mEq/L) and hypomagnesemia (serum magnesium level below 1.2 mEq/L)
Timepoint
Serum potassium and magnesium levels are determined in the first and last days of the intervention (Days 1 & 7).
Method of measurement
Measurement of serum electrolytes using an autoanalyzer device

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: Includes 20 patients who received 500 ml of normal saline before injection of amphotericin and 1.5 vial sodium bicarbonate vial in 500 cc dextrose water, equivalent to the normal saline mEq 159, sodium bicarbonate is given to patients.
Category
Prevention

2

Description
Control group: Includes 20 patients with 1000 ml normal saline 0.9% equivalent to 159 mEq in two divided doses (500 ml) before and after infusion of amphotericin is given to patients.
Category
Prevention

Recruitment centers

1

Recruitment center
Name of recruitment center
Namazi Hospital of Shiraz
Full name of responsible person
Iman Karimzadeh
Street address
Namazi Hospital - Namazi Hospital
City
shiraz
Province
Fars
Postal code
7316-11351
Phone
+98 71 4332 3647
Email
karimzadehiman@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Younes Ghasemi
Street address
Shiraz University of Medical Sciences, next to the Red Crescent,Zand Street, Shiraz
City
shiraz
Province
Fars
Postal code
71348-14336
Phone
+98 71 7282 3235
Email
ghasemiy@sums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Iman Karimzadeh
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Medical Pharmacy
Street address
Akbarabad-Street Entrepreneur-Faculty of Pharmacy-Department of Clinical Pharmacology
City
shiraz
Province
Fars
Postal code
۷۱۴۶۸۶۴۶۸۵
Phone
+98 71 3242 5374
Email
karimzadehiman@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Iman Karimzadeh
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Medical Pharmacy
Street address
Akbarabad, St. Entrepreneur - Faculty of Pharmacy -Department of Clinical Pharmacy
City
shiraz
Province
Fars
Postal code
۷۱۴۶۸۶۴۶۸۵
Phone
+98 71 3242 5305
Email
karimzadehiman@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Iman karimzadeh
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Medical Pharmacy
Street address
Akbarabad School of Pharmacy - Department of Clinical Pharmacy
City
shiraz
Province
Fars
Postal code
71348-14336
Phone
+98 71 3242 4127
Email
karimzadehiman@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
No more information
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...